Jun 10, 2026 07:30AM
Jun 10, 2026 07:30AM
Jun 6, 2026 06:33AM
Jun 6, 2026 05:15AM
May 18, 2026 05:00PM
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Nov 20, 2025 07:13AM
Nov 20, 2025 07:00AM
Jun 1, 2025 08:21AM
May 22, 2025 05:15PM
Apr 16, 2025 07:00AM
Apr 16, 2025 07:00AM
Jun 3, 2024 05:53AM Cullinan Therapeutics (CGEM) Reports Positive Initial Data from Phase 2b REZILIENT1 Study of Zipalertinib
Feb 14, 2023 05:44AM
Jan 6, 2021 04:48PM

66,683 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All